-
2
-
-
0037463608
-
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
-
Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003, 163:427-436.
-
(2003)
Arch Intern Med
, vol.163
, pp. 427-436
-
-
Park, Y.W.1
Zhu, S.2
Palaniappan, L.3
Heshka, S.4
Carnethon, M.R.5
Heymsfield, S.B.6
-
3
-
-
0032937019
-
Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group
-
Connelly P.W., Petrasovits A., Stachenko S., MacLean D.R., Little J.A., Chockalingam A. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999, 15:428-433.
-
(1999)
Can J Cardiol
, vol.15
, pp. 428-433
-
-
Connelly, P.W.1
Petrasovits, A.2
Stachenko, S.3
MacLean, D.R.4
Little, J.A.5
Chockalingam, A.6
-
4
-
-
33846970555
-
Metabolic syndrome: a multiplex cardiovascular risk factor
-
Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92:399-404.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 399-404
-
-
Grundy, S.M.1
-
5
-
-
34248666075
-
Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism
-
Henneman P., Schaap F.G., Havekes L.M., Rensen P., Frants R., van Tol A., et al. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Atherosclerosis 2007, 193:129-134.
-
(2007)
Atherosclerosis
, vol.193
, pp. 129-134
-
-
Henneman, P.1
Schaap, F.G.2
Havekes, L.M.3
Rensen, P.4
Frants, R.5
van Tol, A.6
-
6
-
-
0141841622
-
A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridaemia
-
Kao J.T., Wen H.C., Chien K.L., Hsu H.C., Lin S.W. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridaemia. Hum Mol Genet 2003, 12:2533-2539.
-
(2003)
Hum Mol Genet
, vol.12
, pp. 2533-2539
-
-
Kao, J.T.1
Wen, H.C.2
Chien, K.L.3
Hsu, H.C.4
Lin, S.W.5
-
7
-
-
33947146635
-
The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study
-
Martinelli N., Trabetti E., Bassi A., Girelli D., Friso S., Pizzolo F., et al. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis 2007, 191:409-417.
-
(2007)
Atherosclerosis
, vol.191
, pp. 409-417
-
-
Martinelli, N.1
Trabetti, E.2
Bassi, A.3
Girelli, D.4
Friso, S.5
Pizzolo, F.6
-
8
-
-
0037112882
-
Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides
-
Talmud P.J., Hawe E., Martin S., Olivier M., Miller G., Rubin E., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002, 11:3039-3046.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 3039-3046
-
-
Talmud, P.J.1
Hawe, E.2
Martin, S.3
Olivier, M.4
Miller, G.5
Rubin, E.6
-
9
-
-
33644511403
-
SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population
-
Wright W.T., Young I.S., Nicholls D.P., Patterson C., Lyttle K., Graham C.A. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population. Atherosclerosis 2006, 185:353-360.
-
(2006)
Atherosclerosis
, vol.185
, pp. 353-360
-
-
Wright, W.T.1
Young, I.S.2
Nicholls, D.P.3
Patterson, C.4
Lyttle, K.5
Graham, C.A.6
-
10
-
-
28444457032
-
Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men
-
Dallongeville J., Cottel D., Montaye M., Codron V., Amouyel P., Helbecque N. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 2006, 106:152-156.
-
(2006)
Int J Cardiol
, vol.106
, pp. 152-156
-
-
Dallongeville, J.1
Cottel, D.2
Montaye, M.3
Codron, V.4
Amouyel, P.5
Helbecque, N.6
-
11
-
-
33646762457
-
Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study
-
Elosua R., Ordovas J.M., Cupples L.A., Lai C., Demissie S., Fox C., et al. Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res 2006, 47:990-996.
-
(2006)
J Lipid Res
, vol.47
, pp. 990-996
-
-
Elosua, R.1
Ordovas, J.M.2
Cupples, L.A.3
Lai, C.4
Demissie, S.5
Fox, C.6
-
12
-
-
33748457716
-
Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke
-
Havasi V., Szolnoki Z., Talian G., Bene J., Komlósi K., Maász A., et al. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 2006, 29:177-183.
-
(2006)
J Mol Neurosci
, vol.29
, pp. 177-183
-
-
Havasi, V.1
Szolnoki, Z.2
Talian, G.3
Bene, J.4
Komlósi, K.5
Maász, A.6
-
13
-
-
30944449042
-
Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan
-
Hsu L.A., Ko Y.L., Chang C.J., Hu C.F., Wu S., Teng M.S., et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 2006, 185:143-149.
-
(2006)
Atherosclerosis
, vol.185
, pp. 143-149
-
-
Hsu, L.A.1
Ko, Y.L.2
Chang, C.J.3
Hu, C.F.4
Wu, S.5
Teng, M.S.6
-
14
-
-
1242341216
-
The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction
-
Hubacek J.A., Skodova Z., Adamkova V., Lanska V., Poledne R. The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 2004, 65:126-130.
-
(2004)
Clin Genet
, vol.65
, pp. 126-130
-
-
Hubacek, J.A.1
Skodova, Z.2
Adamkova, V.3
Lanska, V.4
Poledne, R.5
-
15
-
-
36849040544
-
Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome
-
Maasz A., Kisfali P., Horvatovich K., Mohás M., Markó L., Csöngei V., et al. Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome. Pathol Oncol Res 2007, 13:243-247.
-
(2007)
Pathol Oncol Res
, vol.13
, pp. 243-247
-
-
Maasz, A.1
Kisfali, P.2
Horvatovich, K.3
Mohás, M.4
Markó, L.5
Csöngei, V.6
-
16
-
-
10744231400
-
Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease
-
Szalai C., Keszei M., Duba J., Prohászka Z., Kozma G.T., Császár A., et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 2004, 173:109-114.
-
(2004)
Atherosclerosis
, vol.173
, pp. 109-114
-
-
Szalai, C.1
Keszei, M.2
Duba, J.3
Prohászka, Z.4
Kozma, G.T.5
Császár, A.6
-
17
-
-
1642465470
-
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study
-
Talmud P.J., Martin S., Taskinen M., Frick M., Nieminen M., Kesäniemi Y., et al. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 2004, 45:750-756.
-
(2004)
J Lipid Res
, vol.45
, pp. 750-756
-
-
Talmud, P.J.1
Martin, S.2
Taskinen, M.3
Frick, M.4
Nieminen, M.5
Kesäniemi, Y.6
-
18
-
-
46849097401
-
Apolipoprotein A5 Gene IVS3+G476A Allelic Variant Confers Susceptibility for Development of Ischemic Stroke
-
Maasz A., Kisfali P., Jaromi L., Horvatovich K., Szolnoki Z., Csongei V., et al. Apolipoprotein A5 Gene IVS3+G476A Allelic Variant Confers Susceptibility for Development of Ischemic Stroke. Circ J 2008, 72:1065-1070.
-
(2008)
Circ J
, vol.72
, pp. 1065-1070
-
-
Maasz, A.1
Kisfali, P.2
Jaromi, L.3
Horvatovich, K.4
Szolnoki, Z.5
Csongei, V.6
-
19
-
-
33947183396
-
Prediction of genetic risk for metabolic syndrome
-
Yamada Y., Kato K., Hibino T., Yokoi K., Matsuo H., Segawa T., et al. Prediction of genetic risk for metabolic syndrome. Atherosclerosis 2007, 191:298-304.
-
(2007)
Atherosclerosis
, vol.191
, pp. 298-304
-
-
Yamada, Y.1
Kato, K.2
Hibino, T.3
Yokoi, K.4
Matsuo, H.5
Segawa, T.6
-
20
-
-
44949179257
-
Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults
-
Komurcu-Bayrak E., Onat A., Poda M., Humphries S.E., Palmen J., Guclu F., et al. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med 2008, 46:778-784.
-
(2008)
Clin Chem Lab Med
, vol.46
, pp. 778-784
-
-
Komurcu-Bayrak, E.1
Onat, A.2
Poda, M.3
Humphries, S.E.4
Palmen, J.5
Guclu, F.6
-
21
-
-
30844467076
-
APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica
-
Ruiz-Narvaez E., Yang Y., Nakanishi Y., Kirchdorfer J., Campos H. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 2005, 46:2605-2613.
-
(2005)
J Lipid Res
, vol.46
, pp. 2605-2613
-
-
Ruiz-Narvaez, E.1
Yang, Y.2
Nakanishi, Y.3
Kirchdorfer, J.4
Campos, H.5
-
22
-
-
33846818292
-
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations
-
Assmann G., Guerra R., Fox G., Cullen P., Schulte H., Willett D., Grundy S.M., et al. Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol 2007, 99:541-548.
-
(2007)
Am J Cardiol
, vol.99
, pp. 541-548
-
-
Assmann, G.1
Guerra, R.2
Fox, G.3
Cullen, P.4
Schulte, H.5
Willett, D.6
Grundy, S.M.7
-
23
-
-
2642539095
-
Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome
-
Deedwania P.C., Hunninghake D.B., Bays H. Effects of lipid-altering treatment in diabetes mellitus and the metabolic syndrome. Am J Cardiol 2004, 93:18-26.
-
(2004)
Am J Cardiol
, vol.93
, pp. 18-26
-
-
Deedwania, P.C.1
Hunninghake, D.B.2
Bays, H.3
-
24
-
-
1842864853
-
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
-
Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002, 11:3031-3038.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 3031-3038
-
-
Pennacchio, L.A.1
Olivier, M.2
Hubacek, J.A.3
Krauss, R.M.4
Rubin, E.M.5
Cohen, J.C.6
-
25
-
-
26444612171
-
Give me A5 for lipoprotein hydrolysis!
-
Merkel M., Heeren J. Give me A5 for lipoprotein hydrolysis!. J Clin Invest 2005, 115:2694-2696.
-
(2005)
J Clin Invest
, vol.115
, pp. 2694-2696
-
-
Merkel, M.1
Heeren, J.2
-
26
-
-
33845750091
-
Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia
-
van der Vleuten G., Isaacs A., Zeng W., Avest E., Talmud P., Dallinga-Thie G., et al. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. Biochim Biophys Acta 2007, 1772:81-88.
-
(2007)
Biochim Biophys Acta
, vol.1772
, pp. 81-88
-
-
van der Vleuten, G.1
Isaacs, A.2
Zeng, W.3
Avest, E.4
Talmud, P.5
Dallinga-Thie, G.6
-
27
-
-
33845340501
-
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
-
Duerr R., Taylor K., Brant S., Rioux J., Silverberg M., Daly M., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
-
(2006)
Science
, vol.314
, pp. 1461-1463
-
-
Duerr, R.1
Taylor, K.2
Brant, S.3
Rioux, J.4
Silverberg, M.5
Daly, M.6
-
28
-
-
12944295219
-
The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins
-
O'Brien PJ, Alborn WE, Sloan JH Ulmer M, Boodhoo A, Knierman M, et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 51:351-359.
-
Clin Chem
, vol.51
, pp. 351-359
-
-
O'Brien, P.J.1
Alborn, W.E.2
Sloan, J.H.3
Ulmer, M.4
Boodhoo, A.5
Knierman, M.6
-
29
-
-
0037451894
-
Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men
-
Waterworth D., Talmud P., Luan J., Flavell D., Byrne C., Humphries S., Wareham N.J., et al. Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men. Biochim Biophys Acta 2003, 1637:200-206.
-
(2003)
Biochim Biophys Acta
, vol.1637
, pp. 200-206
-
-
Waterworth, D.1
Talmud, P.2
Luan, J.3
Flavell, D.4
Byrne, C.5
Humphries, S.6
Wareham, N.J.7
-
30
-
-
1842765649
-
Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11
-
Olivier M., Wang X., Cole R., Gau B., Kim J., Rubin E., Pennacchio L., et al. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 2007, 83:912-923.
-
(2007)
Genomics
, vol.83
, pp. 912-923
-
-
Olivier, M.1
Wang, X.2
Cole, R.3
Gau, B.4
Kim, J.5
Rubin, E.6
Pennacchio, L.7
|